Skip to main content

Hemodynamic Support

  • Chapter
  • First Online:
Abdominal Sepsis

Part of the book series: Hot Topics in Acute Care Surgery and Trauma ((HTACST))

  • 1532 Accesses

Abstract

Septic shock is a common clinical situation and is associated with a high morbidity and mortality. Appropriate shock approach and support rely on a good understanding of its pathophysiology. Septic shock secondary to abdominal focus presents all the characteristics common to septic shock of other anatomical sources plus two additional and particular ones, namely, increased intra-abdominal pressure and reduction of splanchnic perfusion. These issues raise specific problems that could change the shock approach, namely, target mean arterial pressure and vasopressor selection. In sepsis-induced hypotension, the first step includes adequate fluid resuscitation. If hypotension persists, patients should be treated early with vasopressors to increase mean arterial pressure and maintain a minimal perfusion pressure. The ideal vasopressor has not yet been found. The discussion around the choice of the “best” vasopressor should be substituted by the discussion about what vasopressor best suits each patient pathophysiological abnormalities, namely, in abdominal sepsis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–53.

    Article  PubMed  Google Scholar 

  2. Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009;302(21):2323–9.

    Article  CAS  PubMed  Google Scholar 

  3. Cardoso T, Carneiro AH, Ribeiro O, Pereira A, Group SS. The Portuguese network data: compliance with the surviving sepsis campaign bundles [abstract]. Intensive Care Med. 2006;32(Suppl 1):S23.

    Google Scholar 

  4. Leligdowicz A, Dodek PM, Norena M, Wong H, Kumar A, Kumar A, et al. Association between source of infection and hospital mortality in patients who have septic shock. Am J Respir Crit Care Med. 2014;189(10):1204–13.

    Article  PubMed  Google Scholar 

  5. Vincent JL, Ince C, Bakker J. Clinical review: Circulatory shock—an update: a tribute to Professor Max Harry Weil. Crit Care. 2012;16(6):239.

    PubMed  PubMed Central  Google Scholar 

  6. Weil MH, Shubin H. Proposed reclassification of shock states with special reference to distributive defects. Adv Exp Med Biol. 1971;23(0):13–23.

    CAS  PubMed  Google Scholar 

  7. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.

    Article  PubMed  Google Scholar 

  8. Dellinger RP. Cardiovascular management of septic shock. Crit Care Med. 2003;31(3):946–55.

    Article  PubMed  Google Scholar 

  9. Shepherd RFJ, Shepherd JT. Control of blood pressure and the circulation in man. In: Mathias RBC, editor. Autonomic failure: a textbook of clinical disorders of the autonomic nervous system. Oxford: Oxford Medical Publications; 1982. p. 78–93.

    Google Scholar 

  10. Bauer PR. Microvascular responses to sepsis: clinical significance. Pathophysiology. 2002;8(3):141–8.

    Article  CAS  PubMed  Google Scholar 

  11. Sladen RN, Landry D. Renal blood flow regulation, autoregulation, and vasomotor nephropathy. Anesthesiol Clin North Am. 2000;18(4):791–807. ix

    Article  CAS  Google Scholar 

  12. Asfar P, Meziani F, Hamel JF, Grelon F, Megarbane B, Anguel N, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370(17):1583–93.

    Article  CAS  PubMed  Google Scholar 

  13. Fernandes LG, Ferreira NR, Cardiga R, Povoa P. Severe hypercalcaemia and colon ischaemia: dehydration as an unusual cause? BMJ Case Rep. 2015;2015:bcr2014208809.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Sartelli M, Viale P, Catena F, Ansaloni L, Moore E, Malangoni M, et al. WSES guidelines for management of intra-abdominal infections. World J Emerg Surg. 2013;8(1):3.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, et al. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA. 2015;314(16):1701–10.

    Article  CAS  PubMed  Google Scholar 

  16. Waechter J, Kumar A, Lapinsky SE, Marshall J, Dodek P, Arabi Y, et al. Interaction between fluids and vasoactive agents on mortality in septic shock: a multicenter, observational study. Crit Care Med. 2014;42(10):2158–68.

    Article  CAS  PubMed  Google Scholar 

  17. Bai X, Yu W, Ji W, Lin Z, Tan S, Duan K, et al. Early versus delayed administration of norepinephrine in patients with septic shock. Crit Care. 2014;18(5):532.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Desjars P, Pinaud M, Bugnon D, Tasseau F. Norepinephrine therapy has no deleterious renal effects in human septic shock. Crit Care Med. 1989;17(5):426–9.

    Article  CAS  PubMed  Google Scholar 

  19. Martin C, Eon B, Saux P, Aknin P, Gouin F. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med. 1990;18(3):282–5.

    Article  CAS  PubMed  Google Scholar 

  20. Takala J. Volume responsive, but does the patient need volume? Intensive Care Med. 2016;42(9):1461–3.

    Article  PubMed  Google Scholar 

  21. Bangash MN, Kong ML, Pearse RM. Use of inotropes and vasopressor agents in critically ill patients. Br J Pharmacol. 2012;165(7):2015–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Leone M, Martin C. Vasopressor use in septic shock: an update. Curr Opin Anaesthesiol. 2008;21(2):141–7.

    Article  PubMed  Google Scholar 

  23. Povoa P, Carneiro AH. Adrenergic support in septic shock: a critical review. Hosp Pract (1995). 2010;38(1):62–73.

    Article  Google Scholar 

  24. Furness JB, Marshall JM. Correlation of the directly observed responses of mesenteric vessels of the rat to nerve stimulation and noradrenaline with the distribution of adrenergic nerves. J Physiol. 1974;239(1):75–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Bohm M, Deutsch HJ, Hartmann D, Rosee KL, Stablein A. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure. J Am Coll Cardiol. 1997;30(4):992–6.

    Article  CAS  PubMed  Google Scholar 

  26. Heck DA, Bylund DB. Mechanism of down-regulation of alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther. 1997;282(3):1219–27.

    CAS  PubMed  Google Scholar 

  27. Tang C, Yang J, Wu LL, Dong LW, Liu MS. Phosphorylation of beta-adrenergic receptor leads to its redistribution in rat heart during sepsis. Am J Phys. 1998;274(4 Pt 2):R1078–86.

    CAS  Google Scholar 

  28. Bracco D. Pharmacologic support of the failing circulation: practice, education, evidence, and future directions. Crit Care Med. 2006;34(3):890–2.

    Article  PubMed  Google Scholar 

  29. Sladen RN. Inotropic agents. In: Vincent JL, editor. 1994 yearbook of intensive care and emergency medicine. Berlin: Springer; 1994. p. 165–78.

    Chapter  Google Scholar 

  30. Bailey JM. Dopamine: one size does not fit all. Anesthesiology. 2000;92(2):303–5.

    Article  CAS  PubMed  Google Scholar 

  31. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998;78(1):189–225.

    Article  CAS  PubMed  Google Scholar 

  32. Lieverse AG, Lefrandt JD, Girbes AR, Smit AJ, Reitsma WD. The effects of different doses of dopamine and domperidone on increases of plasma norepinephrine induced by cold pressor test in normal man. Hypertens Res. 1995;18(Suppl 1):S221–4.

    Article  CAS  PubMed  Google Scholar 

  33. Hollenberg SM. Vasoactive drugs in circulatory shock. Am J Respir Crit Care Med. 2011;183(7):847–55.

    Article  CAS  PubMed  Google Scholar 

  34. Sato S, Ohnishi K, Sugita S, Okuda K. Splenic artery and superior mesenteric artery blood flow: nonsurgical Doppler US measurement in healthy subjects and patients with chronic liver disease. Radiology. 1987;164(2):347–52.

    Article  CAS  PubMed  Google Scholar 

  35. Zeng C, Zhang M, Asico LD, Eisner GM, Jose PA. The dopaminergic system in hypertension. Clin Sci (Lond). 2007;112(12):583–97.

    Article  CAS  Google Scholar 

  36. Alexander SP, Mathie A, Peters JA. Guide to receptors and channels (GRAC), 5th edition. Br J Pharmacol. 2011;164(Suppl 1):S1–324.

    Article  CAS  PubMed  Google Scholar 

  37. Bearn AG, Billing B, Sherlock S. The effect of adrenaline and noradrenaline on hepatic blood flow and splanchnic carbohydrate metabolism in man. J Physiol. 1951;115(4):430–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Hoffbrand BI, Forsyth RP. Regional blood flow changes during norepinephrine, tyramine and methoxamine infusions in the unanesthetized rhesus monkey. J Pharmacol Exp Ther. 1973;184(3):656–61.

    CAS  PubMed  Google Scholar 

  39. Beale RJ, Hollenberg SM, Vincent JL, Parrillo JE. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med. 2004;32(11 Suppl):S455–65.

    Article  PubMed  Google Scholar 

  40. Levy B. Lactate and shock state: the metabolic view. Curr Opin Crit Care. 2006;12(4):315–21.

    Article  PubMed  Google Scholar 

  41. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med. 1997;25(8):1279–82.

    Article  CAS  PubMed  Google Scholar 

  42. Strohmenger HU, Krismer A, Wenzel V. Vasopressin in shock states. Curr Opin Anaesthesiol. 2003;16(2):159–64.

    Article  PubMed  Google Scholar 

  43. Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma. 1999;47(4):699–703.

    Article  CAS  PubMed  Google Scholar 

  44. Holmes CL, Patel BM, Russell JA, Walley KR. Physiology of vasopressin relevant to management of septic shock. Chest. 2001;120(3):989–1002.

    Article  CAS  PubMed  Google Scholar 

  45. Sharshar T, Carlier R, Blanchard A, Feydy A, Gray F, Paillard M, et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med. 2002;30(3):497–500.

    Article  CAS  PubMed  Google Scholar 

  46. Leone M, Boyle WA. Decreased vasopressin responsiveness in vasodilatory septic shock-like conditions. Crit Care Med. 2006;34(4):1126–30.

    Article  CAS  PubMed  Google Scholar 

  47. Barrett LK, Orie NN, Taylor V, Stidwill RP, Clapp LH, Singer M. Differential effects of vasopressin and norepinephrine on vascular reactivity in a long-term rodent model of sepsis. Crit Care Med. 2007;35(10):2337–43.

    Article  CAS  PubMed  Google Scholar 

  48. Holmes CL. Vasoactive drugs in the intensive care unit. Curr Opin Crit Care. 2005;11(5):413–7.

    Article  PubMed  Google Scholar 

  49. Morelli A, Rocco M, Conti G, Orecchioni A, De Gaetano A, Cortese G, et al. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock. Intensive Care Med. 2004;30(4):597–604.

    Article  PubMed  Google Scholar 

  50. Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35(1):33–40.

    Article  CAS  PubMed  Google Scholar 

  51. Rehberg S, Ertmer C, Vincent JL, Morelli A, Schneider M, Lange M, et al. Role of selective V1a receptor agonism in ovine septic shock. Crit Care Med. 2011;39(1):119–25.

    Article  CAS  PubMed  Google Scholar 

  52. Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Laderchi A, et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Crit Care. 2008;12(6):R143.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Riekenberg S, Farhat K, Debarry J, Heine H, Jung G, Wiesmuller KH, et al. Regulators of G-protein signalling are modulated by bacterial lipopeptides and lipopolysaccharide. FEBS J. 2009;276(3):649–59.

    Article  CAS  PubMed  Google Scholar 

  54. Bernardin G, Strosberg AD, Bernard A, Mattei M, Marullo S. Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med. 1998;24(12):1315–22.

    Article  CAS  PubMed  Google Scholar 

  55. Wu LL, Yang SL, Yang RC, Hsu HK, Hsu C, Dong LW, et al. G protein and adenylate cyclase complex-mediated signal transduction in the rat heart during sepsis. Shock. 2003;19(6):533–7.

    Article  CAS  PubMed  Google Scholar 

  56. Kadoi Y, Saito S, Kawahara F, Nishihara F, Goto F. G-protein coupled receptor kinase 2 is altered during septic shock in rats. J Surg Res. 2002;108(1):69–76.

    Article  CAS  PubMed  Google Scholar 

  57. Choi WI, Kwon KY, Seo JW, Beagle J, Quinn DA, Hales CA. The role of phosphodiesterase 3 in endotoxin-induced acute kidney injury. BMC Infect Dis. 2009;9:80.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Reinelt H, Radermacher P, Fischer G, Geisser W, Wachter U, Wiedeck H, et al. Effects of a dobutamine-induced increase in splanchnic blood flow on hepatic metabolic activity in patients with septic shock. Anesthesiology. 1997;86(4):818–24.

    Article  CAS  PubMed  Google Scholar 

  59. Albanese J, Leone M, Garnier F, Bourgoin A, Antonini F, Martin C. Renal effects of norepinephrine in septic and nonseptic patients. Chest. 2004;126(2):534–9.

    Article  CAS  PubMed  Google Scholar 

  60. Jhanji S, Stirling S, Patel N, Hinds CJ, Pearse RM. The effect of increasing doses of norepinephrine on tissue oxygenation and microvascular flow in patients with septic shock. Crit Care Med. 2009;37(6):1961–6.

    Article  CAS  PubMed  Google Scholar 

  61. De Backer D, Creteur J, Silva E, Vincent JL. Effects of dopamine, norepinephrine, and epinephrine on the splanchnic circulation in septic shock: which is best? Crit Care Med. 2003;31(6):1659–67.

    Article  PubMed  Google Scholar 

  62. Albert M, Losser MR, Hayon D, Faivre V, Payen D. Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits. Crit Care Med. 2004;32(9):1891–8.

    Article  CAS  PubMed  Google Scholar 

  63. Annane D, Vignon P, Renault A, Bollaert PE, Charpentier C, Martin C, et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet. 2007;370(9588):676–84.

    Article  CAS  PubMed  Google Scholar 

  64. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J. A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med. 2008;34(12):2226–34.

    Article  PubMed  Google Scholar 

  65. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779–89.

    Article  PubMed  Google Scholar 

  66. Dunser MW, Mayr AJ, Ulmer H, Knotzer H, Sumann G, Pajk W, et al. Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation. 2003;107(18):2313–9.

    Article  PubMed  Google Scholar 

  67. Russell JA, Walley KR, Singer J, Gordon AC, Hebert PC, Cooper DJ, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med. 2008;358(9):877–87.

    Article  CAS  PubMed  Google Scholar 

  68. Muller S, How OJ, Hermansen SE, Stenberg TA, Sager G, Myrmel T. Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia. Crit Care. 2008;12(1):R20.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Simon F, Giudici R, Scheuerle A, Groger M, Asfar P, Vogt JA, et al. Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial. Crit Care. 2009;13(4):R113.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med. 2001;345(19):1368–77.

    Article  CAS  PubMed  Google Scholar 

  71. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med. 2004;32(9):1825–31.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pedro Povoa .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Cite this chapter

Povoa, P., Carneiro, A. (2018). Hemodynamic Support. In: Sartelli, M., Bassetti, M., Martin-Loeches, I. (eds) Abdominal Sepsis. Hot Topics in Acute Care Surgery and Trauma. Springer, Cham. https://doi.org/10.1007/978-3-319-59704-1_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-59704-1_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-59703-4

  • Online ISBN: 978-3-319-59704-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics